StonvexLoading…
StonvexStonvexStonvexCore line items from PEP's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-27 | Annual 2024 2024-12-28 | Annual 2023 2023-12-30 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $93.92B | $91.85B | $91.47B | $86.39B |
Operating Income | $11.50B | $12.89B | $11.99B | $11.51B |
Net Income | $8.24B | $9.58B | $9.07B | $8.91B |
EPS (Diluted) | $6.00 | $6.95 | $6.56 | $6.42 |
Total Assets | $107.40B | $99.47B | $100.50B | $92.19B |
Total Liabilities | $86.85B | $81.30B | $81.86B | $74.91B |
Cash & Equivalents | $9.16B | $8.51B | $9.71B | $4.95B |
Free Cash Flow OCF − CapEx | $7.67B | $7.19B | $7.92B | $5.60B |
Shares Outstanding | 1.37B | 1.38B | 1.38B | 1.39B |